Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03604211

SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience

Sponsor: Kantonsspital Graubünden

View on ClinicalTrials.gov

Summary

Single-institution retrospective analysis for predictive factors of prostate cancer patients presenting with isolated or limited lymph node (LN) recurrence (1-3 lesions) on F-Ccholine PET-CT (CholPET) treated with SBRT between January 2010 and July 2015.

Official title: Predictive Factors for the Benefit of Stereotactic Body Radiotherapy for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience

Key Details

Gender

MALE

Age Range

18 Years - 85 Years

Study Type

OBSERVATIONAL

Enrollment

25

Start Date

2010-01

Completion Date

2018-07

Last Updated

2026-11-20

Healthy Volunteers

Not specified

Interventions

RADIATION

Cyberknife Radiation Therapy

Stereotactic Radiotherapy of lymphnode recurrence after prostatectomy +/- salvage radiotherapy

Locations (1)

Juergen Curschmann

Zurich, Switzerland